drugset

drugset / Trial / NCT00002212

A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma

NCT00002212 ↗

Phase 2 Completed 27 enrolled Ligand Pharmaceuticals

Treatment

Summary

The purpose of this study is to see if it is safe and effective to give Targretin capsules to patients with AIDS-related Kaposi's sarcoma (KS).

Timeline

Start: —
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Bexarotene	Small molecule	—	—

Indications